Skip to main content
CONConcentra Group Holdings ParentSell6.0·$40.59
SellModerate Confidence
Investment thesis

Concentra has advanced above its near-term resistance ceiling with no upside remaining and a negative risk/reward, while two deep revenue concentration risks — a single service category (occupational health) accounting for 93% of revenue and a single payer class (workers' compensation carriers) supplying 61% — limit the margin of safety at current prices.

Thesis pillars

  • Workers Comp Carrier Customer Concentration↓Deteriorating
  • Overbought Momentum Elevated Implied Volatility↓Deteriorating
  • Price Above Resistance Ceiling↓Deteriorating
  • +1 more pillar — see the Why tab for full reasoning

Pillars as of Jul 3, 2026, based on the 10-K filed Feb 26, 2026

Full reasoning →

Open full analysis

Concentra Group Holdings Parent (CON) Stock Analysis

SellVALUE-TRAP 1/5GrowthQualityModerate Confidence

Healthcare · Medical Care Facilities

Earnings in 7 days (2026-11-05). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Sell if holding. At $40.59, A.R:R is negative (-0.7) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Product: occupational health centers (93.0%); Concentration risk — Customer: workers' compensation insurance carriers (60.9%).

Concentra Group Holdings Parent is the largest U.S. occupational health services provider by number of locations, operating 628 stand-alone occupational health centers in 41 states and 411 onsite health clinics at employer worksites in 44 states. Revenue was $2,163.4 million in... Read more

$40.59-10.0% A.UpsideScore 6.0/10#7 of 35 Medical Care Facilities
QualityF-score6 / 9FCF yield3.96%
IncomeYield0.62%Payout16.13%sustainable
Stop $38.69Analyst target $36.54(reached)A.R:R -0.7:1
Analyst consensus$42.00+3.5%10 analysts
$40.59price
$42.00mean
$47

Sell if holding. At $40.59, A.R:R is negative (-0.7) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Product: occupational health centers (93.0%); Concentration risk — Customer: workers' compensation insurance carriers (60.9%). Chart setup: No clear chart pattern; technical signals are mixed. Score 6.0/10, moderate confidence.

Passes 4/7 gates (positive momentum, clean insider activity, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio and earnings proximity 7d<=7d. Suitability: moderate.

10-K grounded · weekly refresh

About Concentra Group Holdings Parent

About Concentra Group Holdings Parent

Concentra Group Holdings Parent operated 628 stand-alone occupational health centers in 41 states and 411 onsite health clinics at employer worksites in 44 states at year-end 2025, serving approximately 53,000 patients each business day on average. The company generated $2,163.4 million in revenue during 2025, with 93% from occupational health centers, 5% from onsite health clinics, and 2% from other businesses including Concentra Telemed and Concentra Pharmacy.

Revenue flows through two primary payer channels: workers' compensation insurance carriers and third-party administrators contributed 60.9% of 2025 revenue, and direct employer services contributed 37.6%, with commercial insurance (including Medicare and Medicaid at less than 1%) making up the remainder. The occupational health centers deliver workers' compensation injury care, physical examinations, drug and alcohol screenings, and vaccinations to employers of all sizes, including 100% of the Fortune 100. Two acquisitions completed in 2025 expanded the network: Nova Medical Centers — 67 centers in five states, acquired March 1, 2025, for $265 million — and Pivot Onsite Innovations — over 240 onsite clinics, acquired June 1, 2025, for $54.4 million. Reimbursement rates for workers' compensation services are set by state fee schedules in 38 states and the District of Columbia, with maximums established by state commissions that Concentra cannot influence.

Show full overview

State workers' compensation fee schedules govern reimbursement in 38 states and the District of Columbia, and the 10-K notes that those commissions may reduce prescribed rates through fee schedule modifications without the company's input. Historically, reimbursement rate growth for workers' compensation visits averaged approximately 3% annually from 2016 to 2025 per company data. The employer services channel — contributing 37.6% of revenue — carries market-based pricing the filing characterizes as substantially lower than workers' compensation reimbursement rates, limiting the margin offset available if state fee schedules soften.

See also: Healthcare · Medical Care Facilities

From Concentra Group Holdings Parent's most recent 10-K filing, extracted June 10, 2026.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Nov 5, 20267d to earnings· next earnings call

Thesis

Rewards
Sector modifier (Healthcare): +0.5
Strong earnings beat streak (3/4)
Strong growth profile
Risks
Concentration risk — Product: occupational health centers (93.0%)
Concentration risk — Customer: workers' compensation insurance carriers (60.9%)
Analyst target reached - limited upside remaining

Key Metrics

P/E (TTM)26.2
P/E (Fwd)22.0
Mkt Cap$5.2B
EV/EBITDA15.6
Profit Mgn8.7%
ROE47.1%
Rev Growth10.0%
Beta0.63
Dividend0.62%
Rating analysts13

Quality Signals

Piotroski F6/9

Options Flow

P/C4.20bearish
IV67%elevated

Concentration Risks(10-K Item 1A)

  • HIGHProductoccupational health centers93%
    10-K Item 1: 'with approximately 93% from occupational health centers, approximately 5% from onsite health clinics, and approximately 2% from other businesses'
  • HIGHCustomerworkers' compensation insurance carriers61%
    10-K Item 1: 'Workers' compensation insurance carriers, workers' compensation third-party administrators and self-insured employers ... 60.9 | %'

Material Events(8-K, last 90d)

  • 2026-04-14Item 5.02MEDIUM
    Dr. John Anderson (EVP and Chief Medical Officer) notified retirement effective December 31, 2026. Company expects to enter consulting agreement with Dr. Anderson for transition support. No disagreement cited.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Support Resistance
0.1
Bollinger
1.0
52w Position
10.0
GatesA.R:R -0.7=NEGATIVEEARNINGS PROXIMITY 7d<=7dExecutive change: officer departure/appointmentMomentum 6.8>=5.5Insider activity: OKSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Moderate
RSI
75 · Overbought
↑ 20D MA↑ 50D MA↑ 200D MAGOLDEN CROSSSupport $34.05Resistance $40.64

Price Targets

A.Upside-10.0%
A.R:R-0.7:1

Position Sizing

ConvictionNone
Suggested %0%
Max %0%
RegimeRisk-Off

Risk Alerts

! Target reached (-10.0% upside)
! Negative risk/reward — downside exceeds upside
! EARNINGS_PROXIMITY:7d<=7d

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-11-05 (7d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is CON stock a buy right now?

Sell if holding. At $40.59, A.R:R is negative (-0.7) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Product: occupational health centers (93.0%); Concentration risk — Customer: workers' compensation insurance carriers (60.9%). Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $38.69. Score 6.0/10, moderate confidence.

What is the CON stock price target?

Analyst target $36.54 reached (−10.0% from $40.59); no take-profit level is published. Prior stop was $38.69. Stop-loss: $38.69.

What are the risks of investing in CON?

Concentration risk — Product: occupational health centers (93.0%); Concentration risk — Customer: workers' compensation insurance carriers (60.9%); Analyst target reached - limited upside remaining.

Is CON overvalued or undervalued?

Concentra Group Holdings Parent trades at a P/E of 26.2 (forward 22.0). TrendMatrix value score: 6.1/10. Verdict: Sell.

What do analysts say about CON?

13 analysts cover CON with a consensus score of 4.2/5. Average price target: $42.

What does Concentra Group Holdings Parent do?Concentra Group Holdings Parent is the largest U.S. occupational health services provider by number of locations,...

Concentra Group Holdings Parent is the largest U.S. occupational health services provider by number of locations, operating 628 stand-alone occupational health centers in 41 states and 411 onsite health clinics at employer worksites in 44 states. Revenue was $2,163.4 million in 2025, with 93% from occupational health centers; 60.9% of revenue came from workers' compensation insurance carriers and third-party administrators.

Related stocks: ASTH (Astrana Health Inc.) · AVAH (Aveanna Healthcare Holdings Inc) · CHE (Chemed Corp) · THC (Tenet Healthcare Corporation) · STLN (Starling Oncology, Inc.)
Home › Stocks › CON

Latest news

Latest News

Stock Titan85d ago
TipRanks148d ago
TradingKey93d ago
TradingKey93d ago
News4JAX177d ago
DirectorsTalk Interviews86d ago
Yahoo Finance91d agoEarnings
TradingKey91d ago
TipRanks182d ago
TipRanks174d ago
Marketscreener.com175d agoEarnings
Kare11.com175d agoEarnings
KING5.com175d agoEarnings
WKYC175d agoEarnings
KTEN175d agoEarnings
PR Newswire175d agoEarnings
Yahoo! Finance Canada175d agoEarnings
TipRanks84d agoEarnings
Investing.com Canada84d ago
Yahoo Finance84d agoEarnings
Loading more...